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Cutaneous manifestations of cytomegalovirus (CMV) in patients without human immunodeﬁciency virus remain rare. Perianal
CMV may be observed due to periodic fecal shedding but may be confused for other pathogens, and deﬁnitive diagnosis requires
histopathologic examination. An instructive case is described, and the literature reviewed.
1.Introduction
Cytomegalovirus (CMV), a member of the Herpesviridae
family of DNA viruses, is an important pathogen in the
immunocompromised host. The patterns of organ involve-
ment and clinical disease can be characteristic in particular
populations, such as gastrointestinal ulceration and hepatitis
following solid organ transplant, retinitis in patients with
acquired immunodeﬁciency syndrome (AIDS), and myelo-
suppression and pneumonitis in bone marrow transplant
patients [1–3]. Cutaneous manifestations, however, partic-
ularly in patients without AIDS, remain rare. We discuss
a case of CMV presenting as perianal plaques in a patient
with central nervous system lymphoma and highlight the
importance of prompt histopathologic diagnosis and early
antiviral therapy.
2.CaseReport
A 47 year-old-man, human immunodeﬁciency virus nega-
tive, with a recent diagnosis of central nervous system lym-
phoma presented with perianal skin lesions and nonbloody
diarrhea. The skin lesions began as nodules that progressed
to a roughened plaque and in the minority, ulceration. The
lesions began eight weeks prior to presentation, were multi-
ple, scattered in the perianal area and upper thigh bilaterally,
and three centimeters at the widest diameter (Figure 1). A
more distinct lesion with irregular border was present over
the sacrum consistent with a decubitus ulcer. The patient
had been diagnosed with a CNS lymphoma six weeks
prior to admission when he presented to another hospital
with lower extremity weakness, saddle anesthesia, and fecal
incontinence, and was found to have a L1-L2 intramedullary
spinal mass. He had emergent surgical resection of the
mass and was treated with high-dose dexamethasone and
further radiation therapy. He was additionally found to
have a right temporal lobe mass that was resected and
pathology was consistent with a B-cell lymphoma with T-cell
inﬁltration. He had no other signiﬁcant past medical history
or immunocompromising condition. The lower extremity
weakness persisted and primarily conﬁned him to bed.
For ongoing fecal incontinence and the nonhealing sacral
decubitusulcer,heultimatelyhadadivertingcolostomy.Two
weeks prior to presentation, his bowel movements became
more liquid in consistency and increased in frequency. He
denied abdominal pain. The perianal skin lesions were not
painful, but the initial loss of sensation from the compressive
spinal mass had not recovered. He remained on a dexam-
ethasonetaperandwastransferredtothishospitalforfurther
evaluation for chemotherapy. His complete blood count was
notable for a normocytic anemia, and his liver function tests
for an elevated alkaline phosphatase. An excisional biopsy of2 Case Reports in Infectious Diseases
Figure 1: Perianal plaques in various stages of eruption.
Figure 2: Skin biopsy with hematoxylin/eosin at 400x power.
Lymphocytic inﬁltrate of dermis with enlarged endothelial cells and
occasional magenta-colored intranuclear inclusions.
one of the skin lesions from the upper thigh was obtained
and sent for pathological examination.
Sections of the pathological specimen revealed a dense
neutrophilic crust with numerous bacteria distributed in
varying sized aggregates, and the underlying epidermis was
acanthotic with artefactual subepidermal clefting. However,
the superﬁcial dermis demonstrated a distinct perivascular
lymphocytic inﬁltrate, and the endothelial cells were mark-
edly enlarged (Figure 2). Some endothelial cells contained
magenta-colored nuclear inclusions consistent with cyto-
megalovirus (CMV) infection which was conﬁrmed by a
positive CMV immunostain (Figure 3). Stains with periodic
acid-Schiﬀ and for acid-fast bacilli were negative.
The patient was treated with intravenous ganciclovir
a tﬁ v em g / k ge v e r yt w e l v eh o u r sf o r2 1d a y sf o l l o w e d
by transition to valganciclovir. A serum CMV viral load
was 16,400copies/mL at treatment initiation and was unde-
tectable after four weeks of treatment. The diarrhea resolved
within two weeks, and the skin lesions had completely
healed at the time of switch to valganciclovir. Based on
pathological ﬁndings and response to treatment, the diag-
nosis of cutaneous CMV was made. The primary mode of
pathogenesis was thought to be local inoculation from fecal
shedding. The diarrhea appeared to be a manifestation of
CMV colitis, but given the commitment to CMV treatment
and the response to therapy, no further investigation was
performed. Unfortunately, the patient later died secondary
Figure 3: Skin biopsy with immunoperoxidase stain at 400x power.
Cytomegalovirus positive cell featured in the center of view.
to complications of an intracranial hemorrhage at the site of
the temporal lobe resection.
3. Discussion
Cutaneous CMV infection is thought to arise from reac-
tivation of latent virus in endothelial cells, by endothelial
colonization in the course of hematogenous dissemination,
or by autoinoculation in perioral or perianal areas by fecal,
urinary or salivary shedding of CMV at the time of immuno-
suppression. The predominant defense against CMV is the
MHC-restricted cytotoxic T cell, with growing evidence for
a contributory role played by CD4+ T cells and humoral
immunity [4]. Certain immunosuppressive regimens such as
induction with antithymocyte globulin are associated with
TNF-α-induced CMV reactivation. Furthermore, mainte-
nancetherapywithcyclosporine,tacrolimus,andprednisone
can suppress cytotoxic cells in a dose-dependent manner.
Earlier reports suggested that the dermis was not conducive
to CMV replication, and that cutaneous manifestation was
only a marker of disseminated disease in a severely immuno-
compromised host. Furthermore, CMV may periodically
colonize perianal decubiti without histopathologic change.
Therefore, deﬁnitive diagnosis requires histology marked
by typical vascular endothelial cytopathic changes; intracy-
toplasmic and intranuclear inclusions aﬀecting capillaries.
Interestingly, histological CMV neuritis has been described
in perianal ulcerations with targeted biopsy and may explain
pain similar to that of varicella zoster [5].
A variety of cutaneous manifestations of CMV have
been described in patients with HIV/AIDS, yet most cases
were concurrently infected with herpes simplex virus. The
majority of lesions found in the perianal area have been
described as ulcers and plaques, yet nodules and macu-
lopapular eruptions, particularly when found elsewhere on
the body have been reported [6], and in severe cases, necrosis
has also been described. Ulcers may be single or multiple
and vary in size with as large as 15cm documented [5]. Like
herpes simplex, pain or pruritis is common but not requisite.
Prior to the availability of ganciclovir, cutaneous CMV
often portended death and diagnosis was frequently made
postmortem. Case series in non-HIV/AIDS patients describeCase Reports in Infectious Diseases 3
excellent clinical response to ganciclovir and reduction in
immunosuppression [6], and this is particularly true for
patients in which antigenemia or serum viral load-based
diagnosis precedes biopsy. There are no trials of treatment
for cutaneous CMV, but duration has been extrapolated
from that of infection in other organs where 14–21 days
of induction with ganciclovir may be adequate [3]. Appro-
priately treated lesions still may require 1-2 months until
complete resolution [5]. As serum levels of valganciclovir are
equivalent to ganciclovir, it is no surprise that case reports
exist of successful cure with valganciclovir alone [7].
This case highlights the importance of increased sus-
picion for cutaneous CMV in patients with underlying
immunosuppression, particularly in areas of the skin prone
to autoinoculation. Diagnosis is based on deﬁnitive histo-
pathology which may not be widespread, and thus one must
maintain a low threshold for excisional biopsy.
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